| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.07 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.076 | 0.07 |